HCRN Annual Report 2018

Hoosier cancer Research Network enjoys a unique synergy with our research collaborators that few others can claim. An Indiana-based nonprofit organization with a nationwide impact, HCRN operates at a crossroads where the interests of academic institutions, health networks, and industry funders merge to create a shared avenue for the development, management, and publication of novel oncology research.

We have done this work for 35 years, and by all measures, we have never done it better than we do now. I want to thank our member investigators, study teams, and the hard-working staff at HCRN for a record-breaking year of activity. Our accomplishments would not be possible without your shared commitment and collaboration.

I would like to encourage all of our members to continue bringing your colleagues and collaborators to HCRN. Your expertise and the full-service operations at HCRN are a powerful combination. We look forward to continuing to provide exceptional research services in 2019 and in the years to come.

Following are a few highlights from our unprecedented year of growth:

Record numbers of investigators and member sites

• 253 investigators are members of HCRN clinical trial working groups.
• 70 academic institutions are HCRN members.
• 61 health networks and independent clinics are HCRN members.

Record engagement with working groups and funders

• 37 Clinical Trial Working Group calls and meetings were held in 2018.
• 24 funders (pharmaceutical, biotech, and other organizations) supported HCRN-managed studies.

Record numbers of approved LOIs, CTAs, open studies, and accruals

• 13 LOIs received budget and protocol approval.
• 20 clinical trial agreements were fully executed.
• 40 studies managed by HCRN were open to accrual at the end of 2018.
• 634 subjects enrolled in studies managed by HCRN.

— Bert H. O’Neil, MD

See the HCRN 2018 Annual Report.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 210 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 8,500 subjects have participated in Hoosier Cancer Research Network clinical trials.